Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene Halts Prostate-Cancer Study for Top-Selling Revlimid
Celgene Halts Prostate-Cancer Study for Top-Selling Revlimid
Celgene Halts Prostate-Cancer Study for Top-Selling Revlimid
Submitted by
admin
on November 23, 2011 - 9:25am
Source:
Bloomberg
News Tags:
prostate cancer
Celgene
Revlimid
Headline:
Celgene Halts Prostate-Cancer Study for Top-Selling Revlimid
Do Not Allow Advertisers to Use My Personal information
